Hepatitis B and C co-infection are independent predictors of progressive kidney disease in hiv-positive, antiretroviral-treated adults

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Mocroft, Amanda ^a   Neuhaus, Jacqueline ^b   Peters, Lars ^c   Ryom, Lene ^c   Bickel, Markus ^d   Grint, Daniel ^a   Koirala, Janak ^e   Szymczak, Aleksandra ^f   Lundgren, Jens ^c,g   Ross, Michael J ^h   Wyatt, Christina M ^h  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d GOETHE UNIVERSITY   (Germany)

^e SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

^g Rigshospitalet   (Denmark)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HYALURONIC ACID; INTERLEUKIN 6; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREDICTION; RNA ANALYSIS; SENSITIVITY ANALYSIS; SERODIAGNOSIS;

ADULT; ANTI-HIV AGENTS; COINFECTION; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HIV SEROPOSITIVITY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; VIREMIA; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84864105768     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040245     Document Type: Article

References (30)

1. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, et al. (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355: 2283-2296.
2. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, et al. (2010) Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation 121: 651-658.
3. Wyatt CM, Hoover DR, Shi Q, Tien PC, Karim R, et al. (2011) Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther 16: 591-596.
4. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, et al. (2005) Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40: 1559-1585.
5. Wyatt CM, Malvestutto C, Coca SG, Klotman PE, Parikh CR, (2008) The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS 22: 1799-1807.
6. Huang JF, Chuang WL, Dai CY, Ho CK, Hwang SJ, et al. (2006) Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link? J Intern Med 260: 255-262.
7. Lee JJ, Lin MY, Yang YH, Lu SN, Chen HC, et al. (2010) Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study. Am J Kidney Dis 56: 23-31.
8. Lai KN, Li PK, Lui SF, Au TC, Tam JS, et al. (1991) Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324: 1457-1463.
9. Cheng JT, Anderson HL Jr, Markowitz GS, Appel GB, Pogue VA, et al. (1999) Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 10: 1566-1574.
10. George E, Nadkarni GN, Estrella MM, Lucas GM, Sperati CJ, et al. (2011) The Impact of Hepatitis C Coinfection on Kidney Disease Related to Human Immunodeficiency Virus (HIV): A Biopsy Study. Medicine (Baltimore) 90: 289-295.
11. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, et al. (2004) The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66: 1145-1152.
12. McGuire BM, Julian BA, Bynon JSJ, Cook WJ, King SJ, et al. (2006) Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 144: 735-741.
13. Butt AA, Wang X, Fried LF, (2011) HCV infection and the incidence of CKD. Am J Kidney Dis 57: 396-402.
14. Abrams D, Levy Y, Losso MH, Babiker A, Collins G, et al. (2009) Interleukin-2 therapy in patients with HIV infection. N Engl J Med 361: 1548-1559.
15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
16. Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S, (2010) Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 56: 32-38.
17. Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, et al. (2011) Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 79: 555-562.
18. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, et al. (1997) Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 113: 1609-1616.
19. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, et al. (2007) FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 46: 32-36.
20. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-526.
21. Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, et al. (2012) HCV viremia increases the incidence of chronic kidney disease in HIV-infected patients. AIDS, in press.
22. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, et al. (1995) Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 109: 540-546.
23. Tang S, Lai FM, Lui YH, Tang CS, Kung NN, et al. (2005) Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 68: 1750-1758.
24. Martin-Carbonero L, Teixeira T, Poveda E, Plaza Z, Vispo E, et al. (2011) Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS 25: 73-79.
25. Sorli ML, Guelar A, Montero M, Gonzalez A, Rodriguez E, et al. (2008) Chronic kidney disease prevalence and risk factors among HIV-infected patients. J Acquir Immune Defic Syndr 48(4): 506-508.
26. Di Biagio A, Rosso R, Vitale F, Cardinale F, Sormani MP, et al. (2011) Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study. Clin Nephrol 75: 518-523.
27. System USRD, (2011) USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States.
28. Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, et al. (2010) Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 24: 1667-1678.
29. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG, (2011) Risk Factors for ESRD in HIV-Infected Individuals: Traditional and HIV-Related Factors. Am J Kidney Dis.
30. Tsui JI, Vittinghoff E, Shlipak MG, O'Hare AM, (2006) Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 17: 1168-1174.